(19)
(11) EP 2 804 952 A2

(12)

(88) Date of publication A3:
17.04.2014

(43) Date of publication:
26.11.2014 Bulletin 2014/48

(21) Application number: 12865606.3

(22) Date of filing: 19.01.2012
(51) International Patent Classification (IPC): 
C12P 21/08(2006.01)
A61K 39/00(2006.01)
C07K 16/00(2006.01)
(86) International application number:
PCT/US2012/021888
(87) International publication number:
WO 2013/109279 (25.07.2013 Gazette 2013/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(71) Applicant: Therapeutic Proteins International, LLC
Chicago, Illinois 60616 (US)

(72) Inventor:
  • WILTON, Rosemarie
    Elmhurst, Illinois 60126 (US)

(74) Representative: LifeTech IP Spies Danner & Partner Patentanwälte PartG mbB 
Elsenheimerstrasse 47a
80687 München
80687 München (DE)

   


(54) STABILIZATION OF THE ANTI-CD20 ANTIBODY RITUXIMAB